Polypharmacy Associated with Cognitive Decline in Newly Diagnosed Parkinson's Disease: A Cross-Sectional Study

AIMS: Polypharmacy is well known to affect cognitive function in community-dwelling older adults. However, the effect of polypharmacy on cognitive function in patients with newly diagnosed Parkinson's disease remains unknown. Here, we evaluated the association between polypharmacy and cognitive...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishii, Nobuyuki, Mochizuki, Hitoshi, Sakai, Katsuya, Ogawa, Go, Shiomi, Kazutaka, Nakazato, Masamitsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787424/
https://www.ncbi.nlm.nih.gov/pubmed/31608098
http://dx.doi.org/10.1159/000502351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787424/
https://www.ncbi.nlm.nih.gov/pubmed/31608098
http://dx.doi.org/10.1159/000502351

Ejemplares similares